ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Fluidigm Corporation

Fluidigm Corporation (FLDM)

3.71
0.00
(0.00%)
Closed March 12 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.71
Bid
3.69
Ask
4.03
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.71
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
79,395,000
Dividend Yield
-
PE Ratio
-3.95
Earnings Per Share (EPS)
-0.94
Revenue
106.34M
Net Profit
-74.66M

About Fluidigm Corporation

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Sl... Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Headquarters
Wilmington, Delaware, USA
Founded
-

FLDM Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FLDM - Frequently Asked Questions (FAQ)

What is the current Fluidigm share price?
The current share price of Fluidigm is US$ 3.71
How many Fluidigm shares are in issue?
Fluidigm has 79,395,000 shares in issue
What is the market cap of Fluidigm?
The market capitalisation of Fluidigm is USD 294.56M
What is the 1 year trading range for Fluidigm share price?
Fluidigm has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Fluidigm?
The price to earnings ratio of Fluidigm is -3.95
What is the cash to sales ratio of Fluidigm?
The cash to sales ratio of Fluidigm is 2.77
What is the reporting currency for Fluidigm?
Fluidigm reports financial results in USD
What is the latest annual turnover for Fluidigm?
The latest annual turnover of Fluidigm is USD 106.34M
What is the latest annual profit for Fluidigm?
The latest annual profit of Fluidigm is USD -74.66M
What is the registered address of Fluidigm?
The registered address for Fluidigm is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Fluidigm website address?
The website address for Fluidigm is www.fluidigm.com
Which industry sector does Fluidigm operate in?
Fluidigm operates in the LAB ANALYTICAL INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRVOCervoMed Inc
US$ 6.15
(160.59%)
158.88M
ZENAZenaTech Inc
US$ 4.5505
(61.94%)
6.89M
OPRXOptimizeRx Corporation
US$ 6.265
(51.33%)
16.41M
SSPEW Scripps Company
US$ 2.05
(43.36%)
18.27M
GRPNGroupon Inc
US$ 13.9807
(43.10%)
11.17M
HITHealth In Tech Inc
US$ 1.32
(-82.31%)
16.78M
SPHLSpringview Holdings Ltd
US$ 1.24
(-79.33%)
11.08M
APDNApplied DNA Sciences Inc
US$ 0.0619
(-57.89%)
36.75M
ZYXIZynex Inc
US$ 3.39
(-51.57%)
4.05M
HEPAHepion Pharmaceuticals Inc
US$ 0.0488
(-41.90%)
81.07M
STISolidion Technology Inc
US$ 0.174899
(38.70%)
584.69M
NVDANVIDIA Corporation
US$ 115.74
(6.42%)
323.85M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.1432
(15.59%)
222.79M
VSTEVast Renewable Ltd
US$ 0.6182
(23.66%)
193.78M
CRVOCervoMed Inc
US$ 6.15
(160.59%)
158.88M

FLDM Discussion

View Posts
manysevens manysevens 3 years ago
FLDM bot this 30 min chart today..

👍️0
Eggplant Eggplant 3 years ago
No. I think they are in deep doo doo. They just held their Q3 conference call, and took ZERO questions. What's that about? I think that level of silence speaks volumes. It looks like they are burning more than $10m of cash a quarter, with only $30m of cash remaining - but it's really only $20m if you net out the $10m of cash borrowed from Silicon Valley Bank term loan during the quarter. The working capital #'s are starting to look a bit strange: sales down, and A/R down commensurately, BUT Inventories UP, and A/P UP! It sure looks like they are stretching their payables. Who wants to do the A/P days calculation? Who wants to read the SVB loan agreement to see if covenants were tripped, or will be shortly?

On 7/27/21 Bloomberg reported that FLDM was working with an advisor and speaking to potential buyers of the company. That was 3 months ago, and: nothing. So today they announce a "Strategic Review . . . to maximize shareholder value". This looks like the trajectory of a distressed company, doesn't it?
👍️0
LongTimeObserver LongTimeObserver 4 years ago
$FLDM Back from the dead?
👍️0
LongTimeObserver LongTimeObserver 4 years ago
Pffft! $FLDM
👍️0
Atlanta1 Atlanta1 4 years ago
06:28
$FLDM
Fluidigm: Trump Administration provides saliva test at surge testing site in Waco, TX (6.75)
"Starting today, communities that are part of the federal surge testing effort for COVID-19, supported by the Trump Administration, have a new option: a test that uses samples of saliva collected by spitting into a sterile container. Made by Fluidigm Corporation and supported in part by the National Institutes of Health (NIH), the easy-to-use saliva test detects SARS-CoV-2, the virus that causes COVID-19, on a molecular level using a microfluidics platform. The accuracy of the test is comparable to other molecular-level tests of nasal swab samples, according to a clinical study conducted by the manufacturer. The U.S. Department of Health and Human Services (HHS) has traditionally provided nasal swab tests from other manufacturers to surge testing sites, which remain a choice for community officials."

https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
👍️0
Ckasper Ckasper 4 years ago
Don’t want to jinx it, but currently the stock is up 90%. Hope that means we’ll see a big gap opening tomorrow.
👍️0
Ckasper Ckasper 4 years ago
Does anybody know, when they are expecting the NHI approval and what is still open regarding the approval?
👍️0
lakingsphan0427 lakingsphan0427 4 years ago
The retarded Newscum of Khalifhurnia should do the same..

Patience is the key here..
👍️0
Hole shot King Hole shot King 5 years ago
Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.

https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83214731/fluidigm-achieves-initial-milestone-under-nih-rapi
👍️0
Hole shot King Hole shot King 5 years ago
8K Item 8.01. Other Events.



From August 13, 2020 through September 3, 2020, Fluidigm Corporation (the “Company”) sold a total of 2,479,517 shares of its common stock for aggregate gross proceeds of approximately $20.9 million before commissions and offering expenses under its previously announced “at-the-market” equity offering program. The sales were completed pursuant to the Open Market Sale AgreementSM with Jefferies LLC dated as of March 4, 2020, which the Company filed as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 5, 2020.


https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83213327/current-report-filing-8-k
👍️0
Ckasper Ckasper 5 years ago
NEWS OUT.
FLDM fulfills first step of NHI requirements.
👍️0
Hole shot King Hole shot King 5 years ago
The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors $FLDM https://newsfilter.io/a/0a76fc698a3e38b64c511d5e5683326e
👍️0
Hole shot King Hole shot King 5 years ago
$FLDM should have a good bounce
👍️0
Ckasper Ckasper 5 years ago
Keep it coming. Gotta be patient
👍️0
Hole shot King Hole shot King 5 years ago
$FLDM Gov of Missouri is working in the "coming weeks" to roll out the saliva based test to all Missouri citizens
👍️0
Hole shot King Hole shot King 5 years ago
$FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/news/regional_news/central_missouri/governor-to-talk-saliva-based-covid-19-test/article_aa493c13-9d63-561b-a78c-e66218ec79e4.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via @newspressnow
👍️0
Ckasper Ckasper 5 years ago
Quick testing is still highly demanded. Especially with schools starting now.
👍️0
jonsmile jonsmile 5 years ago
Not sure it might be over it’s all about the cure now
👍️0
Ckasper Ckasper 5 years ago
Agree. That’s why I’m saying it’s going up from here.
👍️0
jonsmile jonsmile 5 years ago
This entire sector has been down

OPK as well
👍️0
Ckasper Ckasper 5 years ago
You here for short gains? That streak would be over now ;)
👍️0
jonsmile jonsmile 5 years ago
LOL counting those chickens I see
👍️0
Ckasper Ckasper 5 years ago
For now
👍️0
jonsmile jonsmile 5 years ago
But it’s red LOL
👍️0
Ckasper Ckasper 5 years ago
Today is the turnaround. First Green Day in a week. Up from here.
👍️0
Ckasper Ckasper 5 years ago
They’ll have to bring out news soon. Implementation in colleges and schools would be the perfect news.
👍️0
lakingsphan0427 lakingsphan0427 5 years ago
Added a few more here..
👍️0
rstar rstar 5 years ago
NIH grant monies and full approval coming next i think- also usage data will hopefully show detection earlier than other tests and greater accuracy $FLDM
👍️0
Ckasper Ckasper 5 years ago
It’ll jump next week again, if they bring out an official statement.
👍️0
Hole shot King Hole shot King 5 years ago
$FLDM

ECHO performer, @fluidigm, has been awarded Emergency Use Authorization (EUA) by the FDA for their saliva-based COVID-19 test. Their microfluidics platform, developed with support from DARPA, has a capacity to conduct up to 6,000 tests per day per system. https://t.co/rE5iNK57wU pic.twitter.com/spb2TvJYDO— DARPA (@DARPA) August 28, 2020

👍️0
Hole shot King Hole shot King 5 years ago
$FLDM Interview on Washington University's new Saliva COVID test

Rich Head, MS, Director, Genome Technology Access Center,
@GenomeInstitute
, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.


Rich Head, MS, Director, Genome Technology Access Center, @GenomeInstitute, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.https://t.co/XEfuhGUsIf— Standard BioTools (@Standard_BioT) August 29, 2020


👍️0
lakingsphan0427 lakingsphan0427 5 years ago
Just added a few more today..
👍️0
Ckasper Ckasper 5 years ago
I like it. Great find
👍️0
Hole shot King Hole shot King 5 years ago
twitter https://www.marketbeat.com/instant-alerts/nasdaq-fldm-a-buy-or-sell-right-now-2020-08/

https://twitter.com/ZolmaxNews


https://zolmax.com/investing/fluidigm-nasdaqfldm-price-target-raised-to-16-00-at-ubs-group/4690037.html

$FLDM
👍️0
Ckasper Ckasper 5 years ago
Where did you see that?
👍️0
lakingsphan0427 lakingsphan0427 5 years ago
Sounds good to me..
👍️0
Hole shot King Hole shot King 5 years ago
Fluidigm $FLDM Price Target Raised to $16.00 at UBS Group
👍️0
Ckasper Ckasper 5 years ago
Hoping for a good post market move, so we can see some additional gain tomorrow.
👍️0
Inspector121 Inspector121 5 years ago
Never stop learning lessons. Priceless.
👍️0
Ckasper Ckasper 5 years ago
I rarely pick it right either, but this was pretty obvious. Thx for the kudos ;)
👍️0
Inspector121 Inspector121 5 years ago
Great call. Wish I had the knowledge to be able to see these things. Thanks
👍️0
Inspector121 Inspector121 5 years ago
Accuracy of that test is questionable. But BP can get away with it. Rigged system. Money talks and FDA listens.
👍️0
lakingsphan0427 lakingsphan0427 5 years ago
WHOA! my $7.65 buys this morning starts to look good..

$20 or better by end of year..
👍️0
Runners123 Runners123 5 years ago
That was a fleeting moment of hype, now a new test is approved that costs $5 and takes 5 minutes for results.
👍️0
Daddy Rick Daddy Rick 5 years ago
I'm at an avg. of $9.41 and feel good about it.

Thinking anything under $10.00 is a REALLY GREAT investment here. BWDIK lol
👍️0
sfast900 sfast900 5 years ago
Bittersweet, I was fine with 1000 shares at 10.
I guess 3200 is what it needed.
Try to get my shares NOW... LOL
👍️0
Ckasper Ckasper 5 years ago
It’ll bottom at 7.50. Then go back to around 9 in the afternoon.
👍️0
Daddy Rick Daddy Rick 5 years ago
Thank You.
👍️0
Inspector121 Inspector121 5 years ago
Abbott tests highly inaccurate.
👍️0
ib12u ib12u 5 years ago
Is this worth getting into? Looks like it took a fall at the opening..
👍️0